Valerie Duchatelle
Overview
Explore the profile of Valerie Duchatelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tavildari A, Alexe R, Ceamburu A, Dallenbach L, Duchatelle V, Jovic D, et al.
Rev Med Suisse
. 2025 Mar;
21(908):442-448.
PMID: 40045834
Coronary CT is pivotal in diagnosing coronary artery disease, addressing epicardial stenosis, vulnerable plaques, and microvascular dysfunction. Technological and AI advancements enable simultaneous anatomical and physiological evaluation. Stenosis assessment now...
2.
[Cardio-oncological risk stratification and follow up: a new challenge for the general practitioner]
Zemare M, Duchatelle V, Alexe R, Djokic B, Sierro C, Girod G
Rev Med Suisse
. 2023 Mar;
19(817):471-476.
PMID: 36883708
Rise of medical oncology, aging of populations and survival rates' improvement of patients suffering from cancer are all factors contributing to exponential rise of the exposure of patients to -cardiotoxic...
3.
Dallenbach L, Pucci L, Duchatelle V, Sierro C, Girod G
Rev Med Suisse
. 2023 Mar;
19(817):460-463.
PMID: 36883706
Despite major therapeutic progress and the numerous poly-pill combinations available on the market today, the control of arterial hypertension remains widely insufficient. A multidisciplinary management putting together internal medicine, nephrology...
4.
Duchatelle V, Delhasse S, Karpuz B, Alexe R, Tapponnier M, Sierro C, et al.
Rev Med Suisse
. 2022 Feb;
18(770):343-346.
PMID: 35224911
Takotsubo cardiomyopathy (TK-CM) is a reversible acute left ventricular dysfunction that cannot be explained by an obstructive coronary lesion. The aim of our study was to explore the possible correlation...
5.
Jeckelmann C, Djokic B, Duchatelle V, Girod G
Eur Heart J Case Rep
. 2022 Feb;
6(2):ytac006.
PMID: 35146323
Background: The SARS-CoV2 virus has been an emerging virus since December 2019 and is the cause of a global pandemic whose clinical manifestations extend far beyond respiratory disease. Case Summary:...
6.
Karpuz B, Duchatelle V, Tapponnier M, Alexe R, Sierro C, Girod G
Rev Med Suisse
. 2017 Jul;
12(529):1475-1478.
PMID: 28675268
The European Society of Cardiology published in 2015 the new Guidelines on the management of pericardial diseases. Based on experts' opinions and recent clinical studies of respectable size, the new...
7.
Stahli B, Gebhard C, Duchatelle V, Cournoyer D, Petroni T, Tanguay J, et al.
J Am Heart Assoc
. 2016 Nov;
5(11).
PMID: 27852589
Background: The Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction (SELECT-ACS) trial suggested beneficial effects of inclacumab, a monoclonal antibody...
8.
Juliard J, Golmard J, Feldman L, Himbert D, Nejjari M, Ducrocq G, et al.
Eur Heart J Acute Cardiovasc Care
. 2015 Mar;
5(2):193-7.
PMID: 25725017
Aim: There is uncertainty as to whether consenting and randomizing patients in randomized clinical trials (RCTs) in acute ST-segment elevation myocardial infarction (STEMI) delays reperfusion and increases mortality. The aim...
9.
Tardif J, Tanguay J, Wright S, Duchatelle V, Petroni T, Gregoire J, et al.
J Am Coll Cardiol
. 2013 Mar;
61(20):2048-55.
PMID: 23500230
Objectives: The study aimed to evaluate inclacumab for the reduction of myocardial damage during a percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation myocardial infarction. Background: P-selectin is an...
10.
Duchatelle V, Kritikou E, Tardif J
Can J Cardiol
. 2012 Aug;
28(6):678-86.
PMID: 22926034
Atherosclerosis and cardiovascular disease are the leading cause of death worldwide. Atherosclerosis is a complex inflammatory disease that results from lipid accumulation and oxidation in the arterial wall combined with...